A clinico-epidemiological study in the highland Himalayan region of Kashmir
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20254117Keywords:
Melasma, Demographical profile, MASI scoring, Epidemiology, CholasmaAbstract
Background: Melasma is an acquired dyschromia present mostly on the sun-exposed areas of the skin. The etiology for melasma is not clear, various factors like genetic or hormonal influences the cause. The aim was to understand the demographical distribution and epidemiological pattern of hyper pigmentation in melasma patients.
Methods: A total of 36 patients participated in the present study at the OPD of Regional Research Institute of Unani Medicine, Srinagar, Kashmir for a period of one year.
Results: In the present study, the mean age of patients with melasma was found to be 30.75±6.74 years, with the age distribution and age of onset ranging between 26 and 36 years. A female preponderance was observed, comprising 29 females and 7 males. Out of the total 36 patients, 21 were married, while 15 were unmarried. The maximum numbers of participants were housewives, and the majority belonged to the upper middle class. Furthermore, 10 patients reported a family history of melasma, whereas 26 patients had no such history.
Conclusions: The present observations demonstrate that the melasma has female predominant, affecting reproductive age group mostly found in upper middle class and housewives.
Metrics
References
Wolff K, Goldsmith LA, Katz SI etal Fitzpatrick’s Dermatology in General Medicine. Seventh edition. McGraw-Hill Medical. 2008.
Sarkar R, Arora P, Garg VK, Gilchrest BA, Paller A, Leffell DJ. Melasma update. Indian Dermatol Online J. 2014;5(4):426. DOI: https://doi.org/10.4103/2229-5178.142484
James WD, Berg TG, Elston DM. Andrews Disease of skin and Clinical Dermatology. 10th Edition. Philadelphia: Saunders Elsevier. 2006;854-5.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatol Surg. 2018;44(6):814-25. DOI: https://doi.org/10.1097/DSS.0000000000001518
Chai Q, Fei Y, Cao H, Wang C, Tian J, Liu J. Acupuncture for melasma in women: a systematic review of randomised controlled trials. Acupunct Med. 2015;33(4):254-61. DOI: https://doi.org/10.1136/acupmed-2014-010633
KrupaShankar DS, Somani VK, Kohli M, Sharad J, Ganjoo A, Kandhari S, et al. A cross-sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther (Heidelb). 2014;4(1):71-81.
Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. Anais Brasileiros de Dermatologia. 2014;89:771-82. DOI: https://doi.org/10.1590/abd1806-4841.20143063
James WD, Berg TG, Elston DM. Andrews Disease of skin and Clinical Dermatology. 10th Edition. Philadelphia: Saunders Elsevier. 2006;854-5.
Bagherani N, Gianfaldoni S, Smoller B. An overview on melasma. Pigmentary Disord. 2015;2(10):218. DOI: https://doi.org/10.4172/2376-0427.1000216
Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25(3):343-52. DOI: https://doi.org/10.1016/j.det.2007.05.004
Rathore SP, Gupta S, Gupta V. Pattern and prevalence of physiological cutaneous changes in pregnancy: A study of 2000 antenatal women. Indian J Dermatol Venereol Leprol. 2011;77(3):402. DOI: https://doi.org/10.4103/0378-6323.79741
Costin GE, Birlea SA. What is the mechanism for melasma that so commonly accompanies human pregnancy? IUBMB Life. 2006;58(1):55-7. DOI: https://doi.org/10.1080/15216540500417020
Ibn Sina. Al-Qanun-Fil-Tibb (Urdu translation by Kantoori GH). Volume 2. New Delhi: Aijaz Publishing House. 2010;1422-4.
Albares Tendero MP, Belinchón Romero I, Ramos Rincón JM, Sánchez Payá J, Costa AL, Pérez Crespo M, et al. Dermatoses in Latin American immigrants seen in a tertiary hospital. Eur J Dermatol. 2009;19(2):157-62. DOI: https://doi.org/10.1684/ejd.2008.0600
Grimes PE, Ijaz S, Nashawati R, Kwak D. New oral and topical approaches for the treatment of melasma. Int J Womens Dermatol. 2018;5(1):30-6. DOI: https://doi.org/10.1016/j.ijwd.2018.09.004
Rodrigues M, Pandya AG. Melasma: clinical diagnosis and management options. Australas J Dermatol. 2015;56(3):151-63. DOI: https://doi.org/10.1111/ajd.12290
Ishiy PS, Silva LR, Penha MÁ, Handel AC, Miot HA. Skin diseases reported by workers from UNESP campus at Rubião Jr, Botucatu-SP (Brazil). An Bras Dermatol. 2014;89(3):529-31. DOI: https://doi.org/10.1590/abd1806-4841.20142875
Griffiths C, Barker J, Bleiker TO. Rook's Textbook of Dermatology. 1st Edition. John Wiley & Sons. 2016;3:2218-20. DOI: https://doi.org/10.1002/9781118441213
Wu MX, Antony R, Mayrovitz HN. Melasma: A Condition of Asian Skin. Cureus. 2021;13(4). DOI: https://doi.org/10.7759/cureus.14398
Sidharth S. Etiopathogenesis of Melasma. In: Sarkar S, editor. Melasma a monograph. 1st Edition. New Delhi: Jaypee Publishers. 2015;6-14. DOI: https://doi.org/10.5005/jp/books/12401_4
Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28(6):648-60. DOI: https://doi.org/10.1111/pcmr.12404
Kang HY, Ortonne JP. What should be considered in treatment of melasma. Ann Dermatol. 2010;22(4):373-8. DOI: https://doi.org/10.5021/ad.2010.22.4.373
Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146(2):228-37. DOI: https://doi.org/10.1046/j.0007-0963.2001.04556.x
Kang HY, Hwang JS, Lee JY, Ahn JH, Kim JY, Lee ES, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006;154(6):1094-9. DOI: https://doi.org/10.1111/j.1365-2133.2006.07179.x
KrupaShankar DS, Somani VK, Kohli M, Sharad J, Ganjoo A, Kandhari S, et al. A cross-sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther (Heidelb). 2014;4(1):71-81. DOI: https://doi.org/10.1007/s13555-014-0046-1
Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011;56(4):380-2. DOI: https://doi.org/10.4103/0019-5154.84722
Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27(2):151-6. DOI: https://doi.org/10.1111/j.1468-3083.2011.04430.x
Adalatkhah H, Sadeghi-Bazargani H. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: A randomized clinical trial. Drug Design Development Therapy. 2015;9:4219-25. DOI: https://doi.org/10.2147/DDDT.S80713
Halder S, Nag SC, Rajesh, Sarkar P. Melasma in the people of Sub Himalayan region of Eastern India. J Pak Assoc Dermatol. 2013;23(2):139-42.
Qazi I, Dogra NK, Dogra D. Melasma: A Clinical and Epidemiological Study. Int J Contemp Med Res. 2017;4(10):2087-90.
Abdalla MA, Nayaf MS, Hussein SZ. Evaluation of Vitamin D in Melasma Patients. Revista Romana de Medicina de Laborator. 2019;27(2):219-22. DOI: https://doi.org/10.2478/rrlm-2019-0023
Tarjuma Sharah Asbab. (Urdu translation by Hakeem KR Ahmed). Vol-4. New Delhi: CCRUM, Ministry of Healyh and Family Welfare. Govt of India. 2010;262-71.
Khan MA. Akseer Azam. Vol-4. Lucknow: Matab Munshi Naval Kishore. 1917;494-500.
Kundu AS, Kumar N, Shekhar C. Kuppuswamy’s Socioeconomic Status Scale-Updating for 2007. Indian J Pediatr. 2007;74:1131-2.
Sarkar R, Jain RK, Puri P. Melasma in Indian Males. Dermatol Surg. 2003;29(2):204. DOI: https://doi.org/10.1097/00042728-200302000-00022
Guinot C, Cheffai S, Latreille J. Aggravating factors for melasma: a prospective study in 167 Tunisian patients. J Eur Acad Dermatol Venereol. 2010;24:1060-9. DOI: https://doi.org/10.1111/j.1468-3083.2010.03592.x